Anixa Biosciences, Inc.

NASDAQ: ANIX    
Share price (12/13/19): $3.26    
Market cap (12/13/19): $65.9 million

Indentures Filter

EX-4.5
from S-3 43 pages Anixa Biosciences, Inc., as Issuer and [ ], as Indenture Trustee Indenture Dated as of [ ]
12/34/56
EX-4.16
from S-8 6 pages Itus Corporation Employee Stock Purchase Plan 1.
12/34/56
EX-4.15
from S-8 2 pages Itus Corporation 2018 Share Incentive Plan Award Agreement
12/34/56
EX-4.14
from S-8 6 pages [Employee] C/O Itus Corporation 3150 Almaden Expressway, Suite 250 San Jose, Ca 95118 Re: Grant of Stock Option to Employee Dear [Employee]:
12/34/56
EX-4.13
from S-8 9 pages Itus Corporation 2018 Share Incentive Plan 1.
12/34/56
EX-4.2
from 10-K 4 pages Warrant to Purchase 500,000 Shares Itus Corporation Common Stock Purchase Warrant
12/34/56
EX-4.6
from S-3 37 pages Itus Corporation, as Issuer and [ ], as Indenture Trustee Indenture Dated as of [ ]
12/34/56
EX-4.21
from S-8 4 pages Indenture or similar
12/34/56
EX-4.1
from 8-K 17 pages Indenture or similar
12/34/56
EX-4
from S-3/A 3 pages Form of Debt Securities
12/34/56
EX-4
from S-3/A 3 pages Form of Subordinated Note Copytele, Inc. [ Title of Security ]
12/34/56
EX-4
from S-3/A 6 pages Subscription Rights Agreement Copytele, Inc. __________
12/34/56
EX-4
from S-3/A 10 pages Common Stock Purchase Warrant Agreement [__________
12/34/56
EX-4
from S-3/A 22 pages Indenture or similar
12/34/56
EX-4
from S-3/A 10 pages Indenture or similar
12/34/56
EX-4
from S-3 34 pages Copytele, Inc., as Issuer and [ ], as Indenture Trustee Indenture Dated as of [ ]
12/34/56
EX-4
from S-3 23 pages Warrant to Purchase 9,249,472 Shares Copytele, Inc. Common Stock Purchase Warrant
12/34/56
EX-4
from S-1 15 pages Registration Rights Agreement
12/34/56
EX-4
from S-8 4 pages C/O CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747 Re: Grant of Non-Qualified Stock Option to Employees Dear ____________:
12/34/56
EX-4
from S-8 5 pages CopyTele, Inc. Has Redacted Certain Confidential Information in This Agreement in Reliance Upon Its Confidential Treatment Request That It Filed With the Securities and Exchange Commission Pursuant to Rule 406 Under the Securities Act of 1933, as Amended. in This Agreement, We Indicate Each Redaction by Use of the Following Symbol [***]. Such Confidential Portions Have Been Omitted and Filed Separately With the Commission).
12/34/56